520 related articles for article (PubMed ID: 27834360)
1. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
[TBL] [Abstract][Full Text] [Related]
2. MiR-21: A key player in glioblastoma pathogenesis.
Masoudi MS; Mehrabian E; Mirzaei H
J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
[TBL] [Abstract][Full Text] [Related]
3. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
Manterola L; Guruceaga E; Gállego Pérez-Larraya J; González-Huarriz M; Jauregui P; Tejada S; Diez-Valle R; Segura V; Samprón N; Barrena C; Ruiz I; Agirre A; Ayuso A; Rodríguez J; González A; Xipell E; Matheu A; López de Munain A; Tuñón T; Zazpe I; García-Foncillas J; Paris S; Delattre JY; Alonso MM
Neuro Oncol; 2014 Apr; 16(4):520-7. PubMed ID: 24435880
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as biomarkers for human glioblastoma: progress and potential.
Huang SW; Ali ND; Zhong L; Shi J
Acta Pharmacol Sin; 2018 Sep; 39(9):1405-1413. PubMed ID: 29417946
[TBL] [Abstract][Full Text] [Related]
5. Small extracellular vesicles as tumor biomarkers for glioblastoma.
Mahmoudi K; Ezrin A; Hadjipanayis C
Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
[TBL] [Abstract][Full Text] [Related]
6. Exosomal noncoding RNAs: key players in glioblastoma drug resistance.
Movahedpour A; Khatami SH; Khorsand M; Salehi M; Savardashtaki A; Mirmajidi SH; Negahdari B; Khanjani N; Naeli P; Vakili O; Taheri-Anganeh M
Mol Cell Biochem; 2021 Nov; 476(11):4081-4092. PubMed ID: 34273059
[TBL] [Abstract][Full Text] [Related]
7. Recent advances of the regulation roles of MicroRNA in glioblastoma.
Yan C; Kong X; Gong S; Liu F; Zhao Y
Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in the EGFR pathway in glioblastoma.
Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma.
McDonald MF; Hossain A; Momin EN; Hasan I; Singh S; Adachi S; Gumin J; Ledbetter D; Yang J; Long L; Daou M; Gopakumar S; Phillips LM; Parker Kerrigan B; Lang FF
Neuro Oncol; 2024 Feb; 26(2):236-250. PubMed ID: 37847405
[TBL] [Abstract][Full Text] [Related]
10. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
Ahir BK; Ozer H; Engelhard HH; Lakka SS
Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
[TBL] [Abstract][Full Text] [Related]
12. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
[TBL] [Abstract][Full Text] [Related]
13. [The action mechanism of glioblastoma cell-derived exosome: a review].
Li N; Luo L; Yang Y; Liu Z; Qiu X; Wang M; Wang W; Xiao X
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1477-1501. PubMed ID: 37154318
[TBL] [Abstract][Full Text] [Related]
14. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
15. Exosomal MicroRNAs in Tumoral U87 MG Versus Normal Astrocyte Cells.
Ipas H; Guttin A; Issartel JP
Microrna; 2015; 4(2):131-45. PubMed ID: 26456536
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
18. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
19. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
Vaidya M; Sugaya K
PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
Mercatelli N; Galardi S; Ciafrè SA
Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
